Arbutus Biopharma | Investor Presentation Deck | 28 slides · page 10 of 28
The slide outlines study design for Part 1, 2, and 3 of a clinical trial for chronic hepatitis B (cHBV).
Pitch deck · appendix_data · analyze_data · dense density
Slide locked Sign in to view
Slide schematic 6/6
list 2/2 paragraph 1/1 source-note 1/1 title 2/2
Components 6
bullet bullet paragraph source-note headline subtitle
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.